Meet the Program Commitee for 2022!

Petra Doerr, PharmD, RPh • Director
European Directorate for the Quality of Medicines and Healthcare (EDQM), France

Sini Eskola, MPharm, MS, MSc • Director Regulatory Strategy
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium

Marco Greco, PhD • President
European Patients' Forum, Belgium

Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands

Niklas Hedberg, MPharm • HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden

Volker Liebenberg • Chief Medical Officer
Elypta, Sweden

Alan Morrison, PhD • Vice President Regulatory Affairs Intl
MSD, United Kingdom

Karen A Noonan, MA • Senior Vice President, Global Regulatory Policy
Association of Clinical Research Organizations (ACRO), United States

Sibilia Quilici • Executive Director
Vaccines Europe, Belgium

Tim Buchanan • Senior Director, Clinical Lead, Tau, Neurology Patient Value Unit
UCB Biopharma, Belgium

Manuel Haas, PharmD, MSc • Executive Director - Regulatory Affairs Europe
MSD UK, United Kingdom

Rebecca Stanbrook, RPh • EFPIA ICH E6(R3) Expert Working Group Member
Switzerland

Matt Popkin, PhD • Senior Director, CMC Excellence, Global Regulatory Affairs
GSK, United Kingdom

Diane Wilkinson, PhD, RPh • Executive Director, Global CMC Regulatory Affairs
AstraZeneca, United Kingdom

Thomas Brookland, MSc • Regulatory Science and Policy Lead
F. Hoffmann-La Roche Ltd, Switzerland

Douglas Gregory • Senior Director, Government Affairs Strategy and Excellence
Bristol Myers Squibb, Belgium

Ronnie Harprit Mundair • Regional Labelling Head - AfME, Canada and LATAM - Senior Director
Pfizer, United Kingdom

Rodrigo Palacios, MBA • Executive Director, Technical Regulatory Policy
F. Hoffmann-La Roche, Switzerland

Henrik K. Nielsen, PhD, MBA, MSc • Vice President
Novo Nordisk A/S, Denmark

Isabelle Stoeckert, PharmD, PMP • Independent Regulatory Science Expert
Independent, Germany

Álmath Spooner, PhD • Head of Europe Regulatory Policy & Intelligence (RPI)
Abbvie, Ireland

Raphael Van Eemeren • EU QPPV Director, Global Patient Safety
Amgen AB, Sweden

Alison Cave, PhD • Chief Safety Officer
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Patrice Verpillat, DrMed, MD, PhD, MPH • Head of Real World Evidence
European Medicines Agency, Netherlands

Rick Vreman • Patient Access Manager
Roche, Netherlands

Nadege Le Roux, PhD • Regulatory Policy Senior Director
Bristol Myers Squibb, Switzerland

Andras Incze • Founder & CEO, Akceso Advisors AG, Switzerland
University Lecturer Healthcare Management, B-W State University, Germany, Switzerland

Piers Mahon • Senior Principal and European Leader
Oncology Evidence Networks, IQVIA, United Kingdom

Bettina Ryll • Member of the First EU Cancer Mission Board
MPNE, Vision Zero Cancer, Sweden

Comité del programa